Building method and application of antibody library
A technology of antibody library and construction method, which is applied in the fields of application, chemical instruments and methods, antibody mimics/scaffolds, etc., can solve the problems of limited and variable available targets, complex antigens, etc., and achieve improved recognition accuracy, high affinity, good specific effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0092] Example 1 Screening of known CD19 and GPC3 antibodies
[0093] The schematic diagram of the synNotch system controlling gene expression in cells is shown in figure 1 , when the extracellular single-chain antibody of the synNotch system recognizes and binds to the antigen, the synNotch system undergoes inducible cleavage of the transmembrane region, thereby releasing the intracellular transcriptional domain into the nucleus, and combining with the upstream cis-activator to activate the expression of the regulated target gene ;
[0094] The schematic diagram of the antibody screening system based on synNotch is shown in figure 2 , based on the synNotch system, the extracellular recognition domain is changed to an extracellular antibody library coding domain, and the regulated target gene is changed to a screening marker gene, thereby obtaining an antibody screening system activated by antigen;
[0095] Screen antibodies specific to CD19 and GPC3 from the known CD19 and...
Embodiment 2
[0109] Example 2. Preparation of antibody library and screening of CD19 antibody expressing cells by flow cytometry
[0110] (1) Construction of a monoclonal cell line stably transfected with a cis-activator and a screening marker gene
[0111] In this embodiment, the cis-activator pTet is used. After receiving the tTA signal, pTet starts the expression of the screening marker green fluorescent protein gene, and artificially synthesizes the entire sequence ( Figure 15 ), constructed into a lentiviral vector. Pack the lentivirus and transfect it into 293T cells. After 3 days, the transfected cells are monoclonalized. Take out a part of the monoclonal cells to be screened and transfect the lentivirus expressing tTA. After 2-3 days, observe with a fluorescence microscope. Select a cell line with green fluorescent expression but no fluorescent expression before transfection, which is a monoclonal cell line that is stably transfected with a cis-activator and a screening marker ge...
Embodiment 3
[0122] Example 3. Preparation of antibody library and drug screening of CD19 antibody expressing cells
[0123] (1) Construct a monoclonal cell line stably transfected with a cis-activator and a selection marker gene;
[0124] In this example, the cis-activator pTet, the screening marker uses iCasp9 negative selection system (SEQ ID NO.21), green fluorescent protein, and puromycin resistance gene, and the three are connected with a 2A sequence that can be automatically broken;
[0125] By artificially synthesizing the entire coding sequence ( Figure 21 ), constructed into a lentiviral vector, packaged lentivirus, transfected into 293T cells, and 3 days later, the transfected cells were monoclonalized; a part of the monoclonal cells to be screened were respectively taken out and transfected to express tTA in Example 1 After 2-3 days, observe with a fluorescence microscope, and select a cell line with green fluorescent expression but no fluorescent expression before transfecti...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com